What does this research mean for the field?

Most cases of acute chest syndrome in children with sickle cell disease are associated with viral infections, suggesting that empiric antibiotic therapy should be limited to ceftriaxone unless respiratory panels confirm atypical bacterial infections. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To review the evolving infectious etiology of acute chest syndrome in pediatric sickle cell disease following routine vaccination and multiplex testing, and to update empiric antibiotic strategies.

September 3, 2026Expert Review of Respiratory Medicine

Management of acute chest syndrome in children with sickle cell disease: impact of vaccination and respiratory panels

View Full Paper

Ask AI

Bookmark

Authors

YZYaoping ZhangState University of New York SVSusannah F. VanderpoolBellevue Hospital Center MHMargaret R. HammerschlagState University of New York

Discussion

Member takes

Implication

Clinical review reports predominant viral etiology of acute chest syndrome in pediatric sickle cell disease, suggesting tailored empiric antibiotics guided by respiratory panels.

Key Points

To review the evolving infectious etiology of acute chest syndrome in pediatric sickle cell disease following routine vaccination and multiplex testing, and to update empiric antibiotic strategies.
Synthesized evidence on pathogen epidemiology in children with sickle cell disease presenting with acute chest syndrome before and after the introduction of conjugate vaccines.
Evaluated diagnostic yields and treatment implications following the clinical implementation of multiplexed PCR respiratory panels since 2014.
Multiplexed PCR panels reveal that viruses cause the majority of pathogen-associated acute chest syndrome events, whereas Mycoplasma pneumoniae and Chlamydia pneumoniae infections occur infrequently.
Expanded conjugate vaccines and penicillin prophylaxis have markedly reduced bacterial complications, leading experts to recommend initial empiric monotherapy with ceftriaxone while reserving azithromycin for panel-confirmed atypical infections.

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/6a9934ea636c6408cfa7cb9a https://doi.org/10.1080/17476348.2026.2725915

View Full Paper

Ask AI

Bookmark

Implication

Clinical review reports predominant viral etiology of acute chest syndrome in pediatric sickle cell disease, suggesting tailored empiric antibiotics guided by respiratory panels.

Management of acute chest syndrome in children with sickle cell disease: impact of vaccination and respiratory panels

Discussion

Member takes

Implication

Key Points

Cite This Study

Management of acute chest syndrome in children with sickle cell disease: impact of vaccination and respiratory panels

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider